Current routine practice and clinico-pathological characteristics associated with acute promyelocytic leukemia in Korea

Sunhyun AHN; Joon-Seong PARK; Seong-Hyun JEONG; Hyun-Woo LEE; Jun-Eun PARK; Mi-Hyang KIM; Yang-Soo KIM; Ho-Sup LEE; Tae-Sung PARK; Eunkyoung YOU; Insoo RHEEM; Joowon PARK; JI-Young HUH; Myung-Seo KANG; Sung-Ran CHO.
Blood Research ; : 31-34, 2013.
Artículo en Inglés | WPRIM | ID: wpr-132583

Documentos relacionados

  1. Early mortality continues to be a barrier to excellent survival in childhood acute promyelocytic leukemia: a retrospective study of 62 patients spanning 17 years.
  2. Acute Promyelocytic Leukemia with del(6)(p22) and Atypical bcr2 PML::RARA Fusion Transcript: A Case Report.
  3. [Leukemic cell kinetics of APL with a novel complex variant t (12;17;15)(p13;q21;q22)].
  4. Identification of concurrent STAT3::RARA and RARA::STAT5b fusions in a variant APL case.
  5. Venetoclax overcomes resistance to all-trans retinoic acid in a variant acute promyelocytic leukemia with TNRC18::RARA fusion.
  6. [Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis].
  7. Inhibition of splicing factors SF3A3 and SRSF5 contributes to As<sup>3+</sup>/Se<sup>4+</sup> combination-mediated proliferation suppression and apoptosis induction in acute promyelocytic leukemia cells.
  8. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study.
  9. Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.
  10. [Therapy-related acute promyelocytic leukemia with complex karyotype accompanied by cryptic PML/RARA on chromosome 15 by metaphase FISH].